② According to documents disclosed by HKEX on September 2,$TENCENT (00700.HK)$,$HSBC HOLDINGS (00005.HK)$And so on to repurchase shares.
Please use your Futubull account to access the feature.$TENCENT (00700.HK)$On August 30, they bought back 2.62 million ordinary shares, involving an amount of HKD 1.002 billion, with a buyback price per share ranging from HKD 385.4 to HKD 377.
Since the share buyback authorization resolution, the cumulative number of repurchased securities is 0.131 billion shares, accounting for 1.389% of the number of issued shares at the time of the ordinary resolution.
Repurchased 3.394 million ordinary shares on May 31, involving an amount of HKD234 million, with a repurchase price per share ranging from HKD69.1 to HKD68.55.$HSBC HOLDINGS (00005.HK)$On August 29, 4.2612 million ordinary shares were repurchased, involving an amount of 0.29 billion Hong Kong dollars, with a repurchase price per share ranging from 68.3 Hong Kong dollars to 67.55 Hong Kong dollars.
Repurchased 1 million ordinary shares on June 3, involving an amount of HKD60.6193 million, with a repurchase price per share ranging from HKD61.15 to HKD59.8.$AIA (01299.HK)$On August 30, 1.11 million ordinary shares were repurchased, involving an amount of 62.6145 million Hong Kong dollars, with a repurchase price per share ranging from 56.95 Hong Kong dollars to 55.5 Hong Kong dollars.
Since the share buyback authorization resolution, the cumulative number of repurchased securities is 0.273 billion shares, accounting for 2.427% of the number of issued shares at the time of the ordinary resolution.
Asymchem Laboratories (06821.HK)$BABA-W (09988.HK)$On August 29, the company repurchased 5.9226 million common shares, involving an amount of 59.9728 million US dollars, with a repurchase price per share ranging from $10.18 to $10.06.
Since the authorization resolution for the share buyback, the cumulative number of repurchased securities is 29.4378 million shares, accounting for 0.15% of the number of issued shares at the time of the ordinary resolution.
Repurchased 2.8 million weighted voting right shares on June 3, involving an amount of HKD50.0474 million, with a repurchase price per share ranging from HKD17.94 to HKD17.82.$CSPC PHARMA (01093.HK)$On August 30, the company repurchased 10.15 million common shares, involving an amount of 49.5504 million Hong Kong dollars, with a repurchase price per share ranging from HK$4.93 to HK$4.84.
Since the authorization resolution for the share buyback, the cumulative number of repurchased securities is 92.11 million shares, accounting for 0.774% of the number of issued shares at the time of the ordinary resolution.
Details of share buybacks by listed companies can be found in the figure below:
What is share buyback?
Share buyback refers to a behavior of listed companies using cash to repurchase a certain amount of outstanding shares on the stock market. After the share buyback, the company can cancel the repurchased shares. This will reduce the number of outstanding shares in circulation, thus achieving positive effects such as market cap management, stock-based incentive, and stable stock price.
